Mechanical Circulatory Support Symposium 2018

Preliminary Program Agenda

This course has been designed to bring you the latest in mechanical circulatory support for both heart (sessions denoted by ) and lung (sessions denoted by  ) indications. There are combined heart and lung sessions covering areas of common interest followed by separate session streams for heart specific and lung specific topics. 

 

Day 1: Thursday, March 8, 2018

7:00 AM

Registration and Continental Breakfast

•   Plenary Session: Hot Topics in Mechanical Circulatory Support for Heart and Lung       
             Moderated by: Shaf Keshavjee, Toronto General Hospital
                                        Jeffery A. Morgan, Texas Heart Institute, Baylor College of Medicine 
                                        
Francis D. Pagani, University of Michigan
                                        Joseph G. Rogers, Duke University
                                       Mark S. Slaughter, University of Louisville, Jewish Hospital 

8:00 AM

Welcome and Opening Remarks
Jeffrey A. Morgan, Texas Heart Institute, Baylor College of Medicine

8:10 AM

Recent Trials With Durable LVADs: Is There a Superior Device? 
Francis D. Pagani, University of Michigan

8:30 AM

Anticoagulation Strategies: Routine, Bleeding and the Heparin Resistant Patient
Charles Hoopes, University of Alabama

8:50 AM

ECMO as a Bridge to Durable LVAD Therapy
Jonathan W. Haft, University of Michigan

9:10 AM

Cross Circulation ECMO for Organ Recovery, Biohybrid Lung and New Devices
Matthew D. Bacchetta, Columbia University Presbyterian Medical Center 

9:30 AM

Stem Cells, Gene Therapy, and Cellular Reprogramming as Adjunctive Therapies for LVAD Recipient as a Bridge to Recovery
Todd K. Rosengart, Texas Heart Institute, Baylor College of Medicine

9:50 AM

Panel Discussion

10:10 AM   

Coffee Break

 •  Session II: Lifetime Recognition Award in MCS and Keynote Lecture

11:00 AM

Dr. O.H. "Bud" Frazier to Recieve Lifetime Achievement Award in MCS
Introduction by Mark S. Slaughter, University of Louisville

11:20 AM

Evolution of Mechanical Circulatory Support and Future Challenges
O.H. Frazier, Texas Heart Institute, Baylor College of Medicine

12:00 PM

Lunch Symposium: ECMO for Cardiac Arrest - Out of Hospital vs. In Hospital
Subhasis Chatterjee, Texas Heart Institute, Baylor College of Medicine
Siavosh Saatee, Texas Heart Institute, Baylor College of Medicine

 Concurrent Session IIIa: Patient Selection & Optimization for Durable MCS Devices 
      Moderated by: Francis D. Pagani, University of Michigan
                                 Ivan Netuka, Institute for Clinical and Experimental Medicine

1:30 PM

Choosing the Optimal Candidate for Durable MCS
Paolo C. Columbo, Columbia Presbyterian Medical Center

1:45 PM

What has INTERMACS Tought Us About Patient Outcomes with Durable MCS?
James K. Kirklin, University of Alabama at Birmingham

2:00 PM

Predicting Outcomes in LVAD Recipients
Sean P. Pinney, Mount Sinai Medical Center

2:15 PM

Timing the Transition from Short to Long-Term MCS or Transplant
Andrew Civitello, Texas Heart Institute, Baylor College of Medicine

2:30 PM

Bridging with Precutaneous Devices - Tandem Heart & Impella
David Baran, Newark Beth Israel Medical Center

2:45 PM

Panel Discussion

3:00 PM

Coffee Break 

• Concurrent Session IIIb: ECLS in Lung Transplantation
     Moderated by: Shaf Keshavjee, Toronto General Hospital
                                Walter Kleptetko, Vienna Medical University 

1:30 PM 

ECLS Bridge to Lung Transplant - Optimizing & Ambulating the Recipient
Shaf Keshavjee, Toronto General Hospital

1:45 PM 

ECLS as a Bridge to Decision in Lung Transplantation
Gabriel Loor, Texas Heart Institute, Baylor College of Medicine

2:00 PM

Optimal Intraoperative Support (Pump vs No Pump, CPB vs ECMO)
Walter Klepetko, Vienna Medical University

2:15 PM 

Optimizing the Donor Lung with EVLP
Marcelo Cypel, University of Toronto

2:30 PM

Preventing/Managing (Severe) PGD
Zachary N. Kon, University of Maryland

2:45 PM

Panel Discussion

3:00 PM

Coffee Break 

 Concurrent Session IVa: Controversial Topics with Device Therapy
     Moderated by: Mark S. Slaughter, University of Louisville, Jewish Hopsital
                                 Ivan Netuka, Institute for Clinical and Experimental Medicine

3:15 PM

Planned, Short-Term RVAD During Durable LVAD Implant: Indications & Mangament
Yoshifumi Naka, Columbia University 

3:30 PM

Results of Durable LVAD Therapy is Improving: Implications for Transplant Listing
Joseph Rogers, Duke University 

3:45 PM

Recovery with Durable LVAD is Underutilized
Nir Uriel, University of Chicago Medicine

4:00 PM

Is 70 Years Too Old for a VAD? 
Stephan Schueler, Newcastle upon Tyne Freeman Hospital

4:15 PM

Surgical Options for Temporary MCS
Michael A. Acker, University of Pennsylvania

4:30 PM

Panel Discussion

4:45 PM

Coffee Break

 Concurrent Session IVb: Trials & Tribulations for Implementing Ex vivo Lung Perfusion in Real Life
    Moderated by: Malcom M. DeCamp, Jr., Northwestern Memorial Hospital
                               Shaf Keshavjee, Toronto General Hospital

Practical Experience in Implementing EVLP

3:15 PM

The Toronto Experience & Current Status
Marcelo Cypel, Toronto General Hospital

3:25 PM

Setting up a Do It Yourself EVLP Program
Tiago Machuca, University of Florida

3:35 PM

EVLP in Partnership with an OPO
Wiliam Lynch, University of Michigan

3:45 PM

EVLP by a Service Provider
Kenneth McCurry, Cleveland Clinic

4:00 PM

Panel Discussion

4:45 PM

Coffee Break

 Session V: MCS Innovation     Not for Credit

5:00 PM

Opening Remarks

5:10 PM

How Far Are We from a Fully Implantable LVAD?
Daniel Zimpfer, Medical University Vienna

5:25 PM

What Will the Next Generation of LVADs Look Like?
Robert L. Kormos, University of Pittsburgh

5:40 PM

LVAD as a Platform for Myocardial Recovery
Stephan Schueler, Newcastle upon Tyne Freeman Hospital

5:55 PM

Total Artificial Heart

6:10 PM

Panel Discussion

6:30 PM

Adjourn

6:30 PM

• • Welcome Reception and Poster Viewing

 

 
 
 
 
 
 
 

Day 2: Friday, March 9, 2018

7:00 AM

Registration and Contiental Breakfast 

  Concurrent Session VIa: MCS Device Thrombosis
       Moderated by: Jeffrey A. Morgan, Texas Heart Institute, Baylor College of Medicine
                                  Stephan Schueler, Newcastle upon Tyne Freeman Hospital

8:00 AM

Diagnosis of Device Thrombosis
Andrew B. Civitello, Texas Heart Institute, Baylor College of Medicine

8:15 AM

Medical Management of Device Thrombosis
Sean P. Pinney, Mount Sinai Health Systems

8:30 AM

Are the Results for Device Exchange Improving? Technique & Outcomes for Device Exchange
Ranjit John, University of Minnesota

8:45 AM

MOMENTUM & ENDURANCE - What Do These Trials Tell Us About Pump Thrombosis
Simon Maltais, Mayo Clinic

9:00 AM

Panel Discussion

9:15 AM

Coffee Break

 Concurrent Session VIb: ECLS Respiratory Failure
    Moderated by: Marcelo Cypel, Toronto General Hospital
                               Daniel Brodie, Columbia University

8:00 AM

Ideal Protective Ventilator Settings for the ARDS Lung on ECMO
Daniel Brodie, Columbia University

8:15 AM

Setting up an ECLS Program
D. Michael McMullan, Seattle Children's Hospital

8:30 AM

Indications & Contradictions for ECLS in Respiratory Failure
William Lynch, University of Michigan

8:45 AM

How to Select Best Cannulation Configuration (VA, VVA, VV with 1 or 2 Cannulae)
Joseph B. Zwishenberger, University of Kentucky 

9:00 AM

Weaning from ECLS: When & How?
R. Duane Davis, Florida Hospital

9:15 AM

Panel Discussion

9:30 AM

Coffee Break

 Session VIIa: Debates on Congroversial Subjects
     Moderated by: Francis D. Pagani, University of Michigan
                                Paolo C. Colombo, Columbia Presbyterian Medical Center

9:45 AM

Class III Patients Should Undergo LVAD Implantation
Pro: Ajith Nair, Texas Heart Institute, Baylor College of Medicine
Con: Sean P. Pinney, Mount Sinai Health System

10:00 AM

Moderate TR Should Be Repaired at the Time of LVAD
Pro: Daniel Zimpfer, Medical University of Vienna
Con: James K. Kirklin, University of Alabama at Birmingham 

10:15 AM

Results with TAH are Superior to BiVAD in Patients with Severe RV Dysfunction
Pro: Jeffrey A. Morgan, Texas Heart Institute, Baylor College of Medicine
Con: Ranjit John, University of Minnesota

10:30 AM

Panel Discussion

10:45 AM

Coffee Break 

• Concurrent Session VIIb: ECLS for Respiratory Failure - Pushing the Boundaries
     Moderated by: R. Duane Davis, Florida Hospital
                               
Joseph B. Zwishenberger, University of Kentucky

9:45 AM

How Far Are We From the "Wearable Lung"?
Bartley P. Griffith, University of Maryland

10:00 AM

ECMO Transport (Air and Ground): Who to Cannulate in the Field & How to Transport
William Lynch, University of Michigan

10:15 AM

eCPR in Adult & Children: How Far is Too Far? 
D. Michael McMullan, Seattle Children's Hospital

10:30 AM

Panel Discussion

10:45 PM

Coffee Break

 • Session VIII: Keynote Lecture
          Introduction by Jeffrey A. Morgan, Texas Heart Institute, Baylor College of Medicine

11:15 AM

Overcoming the Limitations of Long-Term MCS Devices: Will Devices Replace Transplantations?
Mark S. Slaughter, University of Louisville, Jewish Hospital

12:00 PM

Lunch Symposia

• Concurrent Session XIa: Minimally Invasive LVAD Insertion, Concomitant Procedures
      Moderated by: Jonathan W. Haft, University of Michigan

1:30 PM

Minimally Invasive Insertion of HVAD
Simon Maltais, Mayo Clinic

1:45 PM

What are the Indications for Tricuspid Valve Repair by LVAD Implant
Ranjit John, University of Minnesota

2:00 PM

Should Severe Mitral Regugitation Be Addressed at LVAD Implant?
Jonathan W. Haft, University of Michigan

2:15 PM

Indications for Intervention and Surgical Techniques to Manage Aortic Insufficiency at LVAD Implant
Ivan Netuka, Institute for Clinical and Experimental Medicine

2:30 PM

Panel Discussion

2:45 PM

Coffee Break

• Concurrent Session IXb: Other Applications for ECLS in Thoracic Surgery
    Moderated by: Matthew Bacchetta, Columbia University
                               Bartley P. Griffth, University of Maryland

1:30 PM

ECMO in Advanced Airway Surgery & Lung Cancer Resections
Walter Klepetko, Vienna Medical University

1:45 PM

IVLP: In Vivo Lung Perfusion in Cancer Therapy & Gene Therapy of the Lung
Marcelo Cypel, University of Toronto

2:00 PM

Mechanical Support Options for PAH Bridge to Lung Transplantation (PA-LA Novalung & other options)
Shaf Keshavjee, Toronto General Hospital

2:15 PM

Mechanisms of Primary Graft Dysfunction in Lung Translation
Ankit Bharat, Northwestern University

2:30 PM

Panel Discussion

2:45 PM

Coffee Break 

 Concurrent Session Xa: Complications with Durable MCS
      Moderated by: Jonathan W. Haft, University of Michigan
                                 Ivan Netuka, Institute for Clinical and Experiemental Medicine

3:15 PM

Gastrointestinal Bleeding: Diagnosis & Management Strategies
Paolo C. Colombo, Columbia Presbyterian Medical Center

3:30 PM

Stroke: Medical & Surgical Approaches to Prevention
Ranjit John, University of Minnesota

3:45 PM

Aortic Insufficiency: How Often Does it Occur & When to Treat 
Simon Maltais, Mayo Clinic

4:00 PM

Recognition & Treatment of Right Ventricular Failure
Robert L. Kormos, University of Pittsburgh, Presbyterian University Hospital 

4:15 PM

Panel Discussion 

4:30 PM 

Adjourn 

• Concurrent Session Xb: Controversies in ECLS
     Moderated by: Marcelo Cypel, Toronto General Hospital
                                William Lynch, University of Michigan

3:15 PM

Indications of Prolongation of ECMO into the Early Post-Operative Period in Lung Transplantation - How I Do It
Walter Klepetko, Vienna Medical University

3:30 PM 

Neurologic Complications of VV & VA ECLS
William Lynch, University of Michigan

3:45 PM

Uncommon Life Saving Indications for ECLS (Trauma, Hypothermia, Airway Obstruction)
Matthew Bacchette, Columbia University

4:00 PM

Long Term Support for Respiratory Failure: What is the Best Configuration - VV ECMO or Oxygenated RVAD?
Charles Hoopes, University of Alabama at Birmingham

4:15 PM

Panel Discussion 

4:30 PM

Adjourn

   

 *Program Subject to Change

 

 W. Randolph Chitwood, Jr & Pedro J. del Nido
 W. Randolph Chitwood, Jr & Pedro J. del Nido
MCS18 Preliminary Program
(Adobe PDF File)